Transarterial Chemoembolization Using Cisplatin Powder in a Rabbit Model of Liver Cancer

Keywords

Cisplatin, Medicine, Embolization, Lipiodol, Hepatocellular carcinoma

References

• No synergistic activity of epirubicin and interferon-α2b in the treatment of hepatocellular carcinomaP.A. Ombrellaro, R.A. Bennett, J.W. Daughtry — 1995
• A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin.Marc B. Garnick, William D. Ensminger, Mervyn Israel — 1979
• Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trialChing‐Lung Lai, Anna Suk‐Fong Lok, Pui–Chee Wu — 1988
• A phase 2 study of cisplatin in patients with hepatocellular carcinoma.Shuichi Okada, Nobuo Okazaki, Haruhiko Nose — 1993
• 'Two-route chemotherapy' using intra-arterial cisplatin and intravenous sodium thiosulfate, its neutralizing agent, for hepatic malignancies.Ryoji Abe, Tsuyoshi Akiyoshi, Fumio Koba — 1988
• Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.Kenichi Takayasu, Y. Shima, Yukio Muramatsu — 1987
• Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinomaHajime Ohishi, Hitoshi Yoshimura, Hideo Uchida — 2004
• Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particles for hepatocellular carcinomaHideo Uchida, Hajime Ohishi, Naoki Matsuo — 1990
• Transcatheter oily chemoembolization of hepatocellular carcinoma.H Nakamura, Toru Hashimoto, Hiromichi Oi — 1989
• The role of cis-platinum in solid-tumor therapy.Lawrence H. Einhorn, Stephen D. Williams — 1979
• Chemoembolization of hepatocellular carcinomas a study of the biodistribution and pharmacokinetics of doxorubicinJean‐Luc Raoul, D. Héresbach, Jean‐François Bretagne — 1992
• Transcatheter arterial embolization as a method of cisplatin-retention enhancement on the VX2 tumor uterus transplantsK Harima, Yoko Harima, Takeo Hasegawa — 2008
• Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaChung‐Mau Lo, Hys Ngan, Wai‐Kuen Tso — 2002
• Changes in hepatic blood flow during regional hyperthermia.Mark A. Burton, D K Kelleher, Jim Codde — 1991
• Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.Josep M. Llovet, María Isabel Real, Xavier Montañá — 2002
• Clinical pharmacokinetics of intraarterial cisplatin in humans.Tanya Campbell, Stephen B. Howell, C E Pfeifle — 1983
• [Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].Naofumi Nagasue, H Yukaya, J Okamura — 1986
• [Behavior of anti-cancer drug of transcatheter hepatic segmental arterial chemoembolization using lipiodol mixed with an anti-cancer drug followed by gelatin sponge assessed by Tc-99m pertechnetate].H Sakaguchi, Hitoshi Yoshimura, Y Nishimura — 1990
• Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.Seishi Maeda, Junji Shibata, Shigetoshi Fujiyama — 2003
• Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinomaKazuto Ueno, Nobuaki Miyazono, Hiroki Inoue — 2000

Cited by

• In vivo evaluation of cisplatin-loaded superabsorbent polymer microspheres for use in chemoembolization of VX2 liver tumors.Noboru Maeda, Keigo Osuga, Kouki Shimazu — 2012
• Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma.Kazuhiro Kasai — 2013
• Time-Course Studies of Implanted Rabbit VX2 Liver Tumors to Identify the Appropriate Time for Starting Hepatic Arterial Embolization in Animal ModelsAkinaga Sonoda, Norihisa Nitta, Ayumi Nitta‐Seko — 2011
• Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma.Kazuhiro Kasai — 2010
• Hepatic Parenchymal Changes following Transcatheter Embolization and Chemoembolization in a Rabbit Tumor ModelYong Wang, Bin Xiong, Bin Liang — 2013
• Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol EmulsionNoboru Maeda, Keigo Osuga, Hiroki Higashihara — 2012
• Future perspectives on the treatment of hepatocellular carcinoma with cisplatin.Toru Ishikawa — 2009
• Dynamic Evolutionary Changes in Blood Flow Measured by MDCT in a Hepatic VX2 Tumor Implant over an Extended 28-day Growth Period: Time-Density Curve AnalysisHanping Wu, Agata A. Exner, Hong Shi — 2009
• Changes in Hepatic Blood Flow During Transcatheter Arterial Infusion with Heated Saline in Hepatic VX2 TumorWei Cao, Jing Li, Zhiqun Wu — 2013
• What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot StudyYusuke Kawamura, Kenji Ikeda, Taito Fukushima — 2013
• Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release.Ke Han, Xin Pan, Meiwan Chen — 2010
• Comparative study of cisplatin‐iodized oil suspension and emulsion for transcatheter arterial chemoembolization of rabbit VX2 liver tumorsTakahiko Mine, Satoru Murata, Tatsuo Ueda — 2012
• Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based StudyRajagopal N. Aravalli, Erik N. K. Cressman — 2015
• Single-bolus regional chemotherapy with doxorubicin versus chemoembolization in a rabbit VX2 tumor model.Sung Ki Cho, Sung Wook Shin, Young Soo — 2011
• A retrospective comparative study of epirubicin–lipiodol emulsion and cisplatin–lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinomaHiraku Yodono, Kunihiro Matsuo, Atsushi Shinohara — 2011
• Efficacy of a Glass Membrane Emulsification Device to Form Mixture of Cisplatin Powder with Lipiodol on Transarterial Therapy for Hepatocellular CarcinomaToshihiro Tanaka, Hideki Iwamoto, Mitsuteru Fujihara — 2021
• The immune-chemo-embolization effect of temperature sensitive gold nanomedicines against liver cancerYiming Liu, Dingwen Shi, Yanqiao Ren — 2022

Related papers

• Fresh platinum complexes with promising antitumor activity.Xiaoyong Wang — 2010
• Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipomaIrene Chen, Sara Q. Perkins, Scott E. Schwartz — 2021
• A comparison of portal vein embolization with poly(2-hydroxyethylmethacrylate) and a histoacryl/lipiodol mixture in patients scheduled for extended right hepatectomy.J Peregrín, R Janousek, Dana Kautznerová — 2015
• Preoperative Embolization for Meningioma Using LipiodolK. Yasui, Yasuhiro Shoda, Tohru Suyama — 1998
• Skin injury after embolization of ITA participating in blood supply of liver cancerPeng Song, Ning Wu, Fu‐Huang Lin — 2015
• Janus particle-engineered structural lipiodol droplets for arterial embolizationSijian Tao, Bingquan Lin, Houwang Zhou — 2023
• Analysis of the Cause of Lipiodol Incompetely Accumulated in Liver Cancer after TACEGao Yuan-an — 2003
• Effects of microspheres combined with lipiodol embolization on hepatocyte proliferation and apoptosis in rats with liver cancerLiguo Xu, Feng Guangsen — 2019